ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.490
-0.110 (-6.88%)
Oct 23, 2026, 10:26 AM EDT - Market open
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $190.22 million as of October 23, 2026. It is the 20,504th most valuable company in the world and the 3,555th biggest in the United States. Its market cap has decreased by 58.45% in one year.
Market Cap
190.22M
Enterprise Value
409.31M
1-Year Change
-58.45%
Global Rank
Country Rank
#3,555 United States
Category
ChartMarket Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $190.22M, a decrease of -90.69%. That is a compound annual growth rate of -30.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 190.22M | -56.50% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anika Therapeutics | 273.41M |
| Aurora Cannabis | 263.03M |
| BioAge Labs | 242.79M |
| Lifecore Biomedical | 241.69M |
| SIGA Technologies | 229.92M |
| Glass House Brands | 222.41M |
| Akebia Therapeutics | 177.32M |
| Journey Medical | 146.46M |